FCER1G and meningioma: Studies have confirmed that FCER1G is an innate immune FCER1G involved in the occurrence and progression of eczema, which affects the prognosis of meningioma, renal cell carcinoma, acute myeloid leukemia, and other diseases by acting on relevant immune pathways [31–33].